, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and
Publication Year: 2018
ERIC RECOMMENDATIONS FOR TP53 MUTATION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA – UPDATE ON METHODOLOGICAL APPROACHES AND RESULTS INTERPRETATION
Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, Kater A, Utoft Niemann C, Gonzalez D, Davi F, Gonzalez Diaz M, Moreno C, Gaidano G, Stamatopoulos K, Rosenquist R, Stilgenbauer S, Ghia P, Pospisilova S & on behalf of the European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) – TP53 network
EFFICACY OF BENDAMUSTINE AND RITUXIMAB AS FIRST SALVAGE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA AND INDIRECT COMPARISON WITH IBRUTINIB: A GIMEMA, ERIC AND UNK CLL FORMU STUDY
Cuneo A, Follows G, Rigolin G M, Piciocchi A, Tedeschi A, Trentin L, Medina Perez A, Coscia M, Laurenti L, Musuraca G, Farina L, Rivas Delgado A, Orlandi E A, Galieni P, Romana Mauro F, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, A Eyre T, Kennedy B, Bowles K M, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P